1406 — Clarity Medical Holding Income Statement
0.000.00%
Last trade - 00:00- HK$238.01m
- HK$121.99m
- HK$190.93m
Annual income statement for Clarity Medical Holding, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 218 | 222 | 225 | 214 | 191 |
| Cost of Revenue | |||||
| Gross Profit | 179 | 185 | 187 | 176 | 154 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 184 | 178 | 205 | 215 | 271 |
| Operating Profit | 34.3 | 44.7 | 19.8 | -1.39 | -79.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 33.2 | 43.8 | 19 | -2.92 | -81.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 26.4 | 35.8 | 13.5 | -3.19 | -75.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 26.4 | 35.8 | 13.5 | -3.19 | -75.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 26.4 | 35.8 | 13.5 | -3.19 | -75.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.06 | 0.074 | 0.063 | -0.009 | -0.107 |